ESOPJun 1, 2026, 05:00 PM
Zentalis Grants 191,000 Stock Options to 2 New Hires
AI Summary
Zentalis Pharmaceuticals announced the grant of non-qualified stock options to purchase an aggregate of 191,000 shares of its common stock to two newly hired employees. These options were granted on June 1, 2026, under the 2022 Employment Inducement Incentive Award Plan, with an exercise price of $3.98 per share. The options have a 10-year term and will vest over four years, subject to continued employment.
Key Highlights
- Zentalis granted 191,000 non-qualified stock options.
- Options were granted to 2 newly hired employees.
- The exercise price is $3.98 per share, matching the closing price on the grant date.
- Options were granted under the 2022 Employment Inducement Incentive Award Plan.
- The stock options have a 10-year term.
- Vesting occurs over four years, with 25% on the first anniversary and the remainder monthly over three years.
Price Impact
More from ZNTL